BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

795 related articles for article (PubMed ID: 3001488)

  • 1. Pathologic analysis of primary brain tumors.
    McComb RD; Burger PC
    Neurol Clin; 1985 Nov; 3(4):711-28. PubMed ID: 3001488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinicopathological study on malignant glioma--with special reference to GFAP].
    Tajika T; Kubo O; Tajika Y; Toyama T; Himuro H; Inoue N; Sakairi M; Kitamura K
    No Shinkei Geka; 1986 Jun; 14(7):831-5. PubMed ID: 3020463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vimentin and glial fibrillary acidic protein in human brain tumors.
    Yung WK; Luna M; Borit A
    J Neurooncol; 1985; 3(1):35-8. PubMed ID: 3889231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Significance of immunohistochemistry in neuro-oncology. I. Demonstration of glial fibrillary acid protein (GFAP) in extracranial metastases from primary brain tumors].
    Gottschalk J; Martin H; Kretschmer B; Barz H; Janda J; Szymas J
    Zentralbl Allg Pathol; 1985; 130(5):391-6. PubMed ID: 3913231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of glial fibrillary acidic protein (GFAP) with grading of the neuroglial tumours.
    Reyaz N; Tayyab M; Khan SA; Siddique T
    J Coll Physicians Surg Pak; 2005 Aug; 15(8):472-5. PubMed ID: 16202357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of glial fibrillary acidic protein, vimentin, fibronectin, and N-myc oncoprotein in primary human brain tumor cell explants.
    Mapstone TB; Galloway PG
    Pediatr Neurosurg; 1991-1992; 17(4):169-74. PubMed ID: 1668298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical localization of glial fibrillary acidic protein in human glial neoplasms.
    Velasco ME; Dahl D; Roessmann U; Gambetti P
    Cancer; 1980 Feb; 45(3):484-94. PubMed ID: 6243508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of monoclonal antibodies to glial fibrillary acidic protein in the cytologic diagnosis of brain tumors.
    Chen Y; Zhang YX
    Acta Cytol; 1989; 33(6):922-8. PubMed ID: 2588925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Significance of immunohistochemistry for neuro-oncology. VI. Occurrence, localization and distribution of glial fibrillary acid protein (GFAP) in 820 tumors].
    Gottschalk J; Szymaś J
    Zentralbl Allg Pathol; 1987; 133(4):319-30. PubMed ID: 3425011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primitive neuroectodermal tumors including the medulloblastoma: glial differentiation signaled by immunoreactivity for GFAP is restricted to the pure desmoplastic medulloblastoma ("arachnoidal sarcoma of the cerebellum").
    Herpers MJ; Budka H
    Clin Neuropathol; 1985; 4(1):12-8. PubMed ID: 3978900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunocytochemical study of the glial fibrillary acidic protein in human neoplasms of the central nervous system.
    Tascos NA; Parr J; Gonatas NK
    Hum Pathol; 1982 May; 13(5):454-8. PubMed ID: 6281168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of gliomas by morphological and immunocytochemical analysis in cell cultures.
    Fazekas I; Kerekes E; Hegedús B; Nyáry I
    Ideggyogy Sz; 2002 May; 55(5-6):173-9. PubMed ID: 12122877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the blood-brain barrier of metastatic and primary malignant neoplasms.
    Nduom EK; Yang C; Merrill MJ; Zhuang Z; Lonser RR
    J Neurosurg; 2013 Aug; 119(2):427-33. PubMed ID: 23621605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomerase activity and alterations in telomere length in human brain tumors.
    Hiraga S; Ohnishi T; Izumoto S; Miyahara E; Kanemura Y; Matsumura H; Arita N
    Cancer Res; 1998 May; 58(10):2117-25. PubMed ID: 9605755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of glial fibrillary acidic protein and protein S-100 in cerebral astrocytic gliomas of varying degrees of malignancy (immunohistochemical study)].
    Korshunov AG; Sycheva RV
    Arkh Patol; 1995; 57(4):30-8. PubMed ID: 8526753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphological features of gliomas in children.
    Hirato J; Nakazato Y
    Noshuyo Byori; 1996 Apr; 13(1):37-47. PubMed ID: 8916125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular markers of primitive neuroectodermal tumors and other pediatric central nervous system tumors. Monoclonal antibodies to neuronal and glial antigens distinguish subsets of primitive neuroectodermal tumors.
    Molenaar WM; Jansson DS; Gould VE; Rorke LB; Franke WW; Lee VM; Packer RJ; Trojanowski JQ
    Lab Invest; 1989 Dec; 61(6):635-43. PubMed ID: 2557487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebral astrocytic neoplasms in the adult: contribution of histologic examination to the assessment of prognosis.
    Fulling KH; Nelson JS
    Semin Diagn Pathol; 1984 May; 1(2):152-63. PubMed ID: 6100972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Embryonal central neuroepithelial tumors and their differentiating potential. A cytogenetic view of a complex neuro-oncological problem.
    Rubinstein LJ
    J Neurosurg; 1985 Jun; 62(6):795-805. PubMed ID: 2987439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of non-glial intermediate filament proteins in gliomas.
    Hirato J; Nakazato Y; Ogawa A
    Clin Neuropathol; 1994; 13(1):1-11. PubMed ID: 7518371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.